MiR-101-3p targets the PI3K-AKT signaling pathway via Birc5 to inhibit invasion, proliferation, and epithelial–mesenchymal transition in hepatocellular carcinoma

Wen‐Yuan Zhu(Shandong University), Chang Hong(Shandong Provincial Hospital)
Clinical and Experimental Medicine
March 19, 2025
Cited by 10


Related Papers